These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 18086940)
1. Is microvolt T-wave alternans the answer to risk stratification in heart failure? Myles RC; Jackson CE; Tsorlalis I; Petrie MC; McMurray JJ; Cobbe SM Circulation; 2007 Dec; 116(25):2984-91. PubMed ID: 18086940 [No Abstract] [Full Text] [Related]
2. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671 [TBL] [Abstract][Full Text] [Related]
3. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls. Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115 [TBL] [Abstract][Full Text] [Related]
4. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Chauhan VS; Selvaraj RJ Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041 [TBL] [Abstract][Full Text] [Related]
5. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy". Madias JE Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15900622 [No Abstract] [Full Text] [Related]
6. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy". Jachuck M; Satchithananda DK Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15897353 [No Abstract] [Full Text] [Related]
8. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804 [TBL] [Abstract][Full Text] [Related]
9. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification]. Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators. Barbosa MPT; da Costa Rocha MO; Neto ES; Brandão FV; Lombardi F; Ribeiro ALP Int J Cardiol; 2016 Nov; 222():80-85. PubMed ID: 27467316 [TBL] [Abstract][Full Text] [Related]
11. [Risk stratification for sudden cardiac death: from the electrophysiological study to T-wave alternans]. Pedretti RF; Sarzi Braga S; Vaninetti R; Laporta A; Masnaghetti S; Raimondo R; Rubin D; Santoro F; Salerno M G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):33S-39S. PubMed ID: 19195304 [TBL] [Abstract][Full Text] [Related]
12. Sudden cardiac death: the role of risk stratification. Kusmirek SL; Gold MR Am Heart J; 2007 Apr; 153(4 Suppl):25-33. PubMed ID: 17394900 [TBL] [Abstract][Full Text] [Related]
13. Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans? Cutler MJ; Rosenbaum DS Heart Rhythm; 2009 Aug; 6(8 Suppl):S56-61. PubMed ID: 19631909 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention. Daccarett M; Serafimovski N; Machado C Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385 [No Abstract] [Full Text] [Related]
15. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307 [TBL] [Abstract][Full Text] [Related]
17. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy". De Ferrari GM; Verrier RL Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521 [No Abstract] [Full Text] [Related]